179 related articles for article (PubMed ID: 16777967)
1. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.
Chen KG; Valencia JC; Lai B; Zhang G; Paterson JK; Rouzaud F; Berens W; Wincovitch SM; Garfield SH; Leapman RD; Hearing VJ; Gottesman MM
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9903-7. PubMed ID: 16777967
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance decreases with mutations of melanosomal regulatory genes.
Xie T; Nguyen T; Hupe M; Wei ML
Cancer Res; 2009 Feb; 69(3):992-9. PubMed ID: 19155314
[TBL] [Abstract][Full Text] [Related]
3. Influence of melanosome dynamics on melanoma drug sensitivity.
Chen KG; Leapman RD; Zhang G; Lai B; Valencia JC; Cardarelli CO; Vieira WD; Hearing VJ; Gottesman MM
J Natl Cancer Inst; 2009 Sep; 101(18):1259-71. PubMed ID: 19704071
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein-trafficking pathways alters melanoma treatment sensitivity.
Huang ZM; Chinen M; Chang PJ; Xie T; Zhong L; Demetriou S; Patel MP; Scherzer R; Sviderskaya EV; Bennett DC; Millhauser GL; Oh DH; Cleaver JE; Wei ML
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):553-8. PubMed ID: 22203954
[TBL] [Abstract][Full Text] [Related]
5. Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1982 Jan; 78(1):76-81. PubMed ID: 7054310
[TBL] [Abstract][Full Text] [Related]
6. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
[TBL] [Abstract][Full Text] [Related]
7. A polymethoxyflavone mixture extracted from orange peels, mainly containing nobiletin, 3,3',4',5,6,7,8-heptamethoxyflavone and tangeretin, suppresses melanogenesis through the acidification of cell organelles, including melanosomes.
Yoshizaki N; Hashizume R; Masaki H
J Dermatol Sci; 2017 Oct; 88(1):78-84. PubMed ID: 28629701
[TBL] [Abstract][Full Text] [Related]
8. Identification of rab7 as a melanosome-associated protein involved in the intracellular transport of tyrosinase-related protein 1.
Gomez PF; Luo D; Hirosaki K; Shinoda K; Yamashita T; Suzuki J; Otsu K; Ishikawa K; Jimbow K
J Invest Dermatol; 2001 Jul; 117(1):81-90. PubMed ID: 11442753
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Mg2+-ATPase activity in isolated B16 murine melanoma melanosomes.
Bhatnagar V; Ramalah A
Mol Cell Biochem; 1998 Dec; 189(1-2):99-106. PubMed ID: 9879659
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.
Kishimoto S; Miyazawa K; Terakawa Y; Ashikari H; Ohtani A; Fukushima S; Takeuchi Y
Jpn J Cancer Res; 2000 Dec; 91(12):1326-32. PubMed ID: 11123433
[TBL] [Abstract][Full Text] [Related]
11. Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.
Watabe H; Valencia JC; Le Pape E; Yamaguchi Y; Nakamura M; Rouzaud F; Hoashi T; Kawa Y; Mizoguchi M; Hearing VJ
J Invest Dermatol; 2008 Jan; 128(1):162-74. PubMed ID: 17687388
[TBL] [Abstract][Full Text] [Related]
12. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma.
Fernández-Pérez MP; Montenegro MF; Sáez-Ayala M; Sánchez-del-Campo L; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
Neoplasia; 2013 Jul; 15(7):826-39. PubMed ID: 23814494
[TBL] [Abstract][Full Text] [Related]
13. FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes.
Jung H; Chung H; Chang SE; Kang DH; Oh ES
Pigment Cell Melanoma Res; 2016 Mar; 29(2):199-209. PubMed ID: 26581186
[TBL] [Abstract][Full Text] [Related]
14. Different ultrastructural feature of keratinocytes in human malignant melanomas.
Klug H; Winter H; Lehnert W
Arch Geschwulstforsch; 1989; 59(2):107-12. PubMed ID: 2470335
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 1998; 44(6):414-20. PubMed ID: 9755302
[TBL] [Abstract][Full Text] [Related]
16. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma.
Borovanský J; Mirejovský P; Riley PA
Neoplasma; 1991; 38(4):393-400. PubMed ID: 1922572
[TBL] [Abstract][Full Text] [Related]
17. Detection of Misdistribution of Tyrosinase from Melanosomes to Lysosomes and Its Upregulation under Psoralen/Ultraviolet A with a Melanosome-Targeting Tyrosinase Fluorescent Probe.
Zhou J; Shi W; Li L; Gong Q; Wu X; Li X; Ma H
Anal Chem; 2016 Apr; 88(8):4557-64. PubMed ID: 27021123
[TBL] [Abstract][Full Text] [Related]
18. Influence of N-glycan processing disruption on tyrosinase and melanin synthesis in HM3KO melanoma cells.
Choi H; Ahn S; Chang H; Cho NS; Joo K; Lee BG; Chang I; Hwang JS
Exp Dermatol; 2007 Feb; 16(2):110-7. PubMed ID: 17222224
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
[TBL] [Abstract][Full Text] [Related]
20. Melanosomal targeting via caveolin-1 dependent endocytosis mediates ZN(II) phthalocyanine phototoxic action in melanoma cells.
Valli F; García Vior MC; Ezquerra Riega SD; Roguin LP; Marino J
J Photochem Photobiol B; 2022 Sep; 234():112505. PubMed ID: 35839543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
